We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 2.20 | 2.00 | 2.40 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMODX
RNS Number : 9229T
Omega Diagnostics Group PLC
18 October 2017
Omega Diagnostics Group PLC
("Omega" or the "Company")
PDMR participation in SAYE scheme
Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that certain PDMRs of the Company have been granted sharesave option awards in the Company's save as you earn scheme ("SAYE Scheme") which gives them the opportunity to participate in the future growth of the Company via share award arrangements.
The SAYE Scheme grants participants the option to purchase ordinary shares of 4 pence each in the capital of the Company ("Ordinary Share") at a price of 18.4 pence per Ordinary Share and is exercisable between 1 November 2020 and 1 May 2021.
Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):
Hot Features
Premium
1) Details of Persons Discharging Managerial
Responsibilities "PDMR" / person closely
associated with them ('PCA')
a) Name John Bannister
2. Reason for notification
b) Position / PDMR
status
c) Initial notification Initial Notification
/ amendment
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
b) Name Omega Diagnostics Group plc
c) LEI 2138007U9P4BTZTYIR92
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
a) Description Options over ordinary shares
of the financial of 4p each
instrument
Identification GB00B1VCP282
code
b) Nature of Grant of share options under
the transaction the Company's SAYE Scheme
c) Price(s) and Price(s) Volume(s)
volume(s) GBP0.184 23,478
d) Aggregated n/a
information
Aggregated
volume Price
e) Date of the 18 October 2017
transaction
f) Place of the Outside a trading venue
transaction
1) Details of Persons Discharging Managerial
Responsibilities "PDMR" / person closely
associated with them ('PCA')
a) Name Derek Brady
2. Reason for notification
b) Position / PDMR
status
c) Initial notification Initial Notification
/ amendment
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
b) Name Omega Diagnostics Group plc
c) LEI 2138007U9P4BTZTYIR92
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
a) Description Options over ordinary shares
of the financial of 4p each
instrument
Identification GB00B1VCP282
code
b) Nature of Grant of share options under
the transaction the Company's SAYE Scheme
c) Price(s) and Price(s) Volume(s)
volume(s) GBP0.184 14,673
d) Aggregated n/a
information
Aggregated
volume Price
e) Date of the 18 October 2017
transaction
f) Place of the Outside a trading venue
transaction
1) Details of Persons Discharging Managerial
Responsibilities "PDMR" / person closely
associated with them ('PCA')
a) Name Patrick Breen
2. Reason for notification
b) Position / PDMR
status
c) Initial notification Initial Notification
/ amendment
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
b) Name Omega Diagnostics Group plc
c) LEI 2138007U9P4BTZTYIR92
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
a) Description Options over ordinary shares
of the financial of 4p each
instrument
Identification GB00B1VCP282
code
b) Nature of Grant of share options under
the transaction the Company's SAYE Scheme
c) Price(s) and Price(s) Volume(s)
volume(s) GBP0.184 19,565
d) Aggregated n/a
information
Aggregated
volume Price
e) Date of the 18 October 2017
transaction
f) Place of the Outside a trading venue
transaction
1) Details of Persons Discharging Managerial
Responsibilities "PDMR" / person closely
associated with them ('PCA')
a) Name Michael Gordon
2. Reason for notification
b) Position / PDMR
status
c) Initial notification Initial Notification
/ amendment
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
b) Name Omega Diagnostics Group plc
c) LEI 2138007U9P4BTZTYIR92
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
a) Description Options over ordinary shares
of the financial of 4p each
instrument
Identification GB00B1VCP282
code
b) Nature of Grant of share options under
the transaction the Company's SAYE Scheme
c) Price(s) and Price(s) Volume(s)
volume(s) GBP0.184 39,130
d) Aggregated n/a
information
Aggregated
volume Price
e) Date of the 18 October 2017
transaction
f) Place of the Outside a trading venue
transaction
1) Details of Persons Discharging Managerial
Responsibilities "PDMR" / person closely
associated with them ('PCA')
a) Name Iain Logan
2. Reason for notification
b) Position / PDMR
status
c) Initial notification Initial Notification
/ amendment
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
b) Name Omega Diagnostics Group plc
c) LEI 2138007U9P4BTZTYIR92
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
a) Description Options over ordinary shares
of the financial of 4p each
instrument
Identification GB00B1VCP282
code
b) Nature of Grant of share options under
the transaction the Company's SAYE Scheme
c) Price(s) and Price(s) Volume(s)
volume(s) GBP0.184 9,782
d) Aggregated n/a
information
Aggregated
volume Price
e) Date of the 18 October 2017
transaction
f) Place of the Outside a trading venue
transaction
1) Details of Persons Discharging Managerial
Responsibilities "PDMR" / person closely
associated with them ('PCA')
a) Name Angela Robertson
2. Reason for notification
b) Position / PDMR
status
c) Initial notification Initial Notification
/ amendment
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
b) Name Omega Diagnostics Group plc
c) LEI 2138007U9P4BTZTYIR92
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
a) Description Options over ordinary shares
of the financial of 4p each
instrument
Identification GB00B1VCP282
code
b) Nature of Grant of share options under
the transaction the Company's SAYE Scheme
c) Price(s) and Price(s) Volume(s)
volume(s) GBP0.184 19,565
d) Aggregated n/a
information
Aggregated
volume Price
e) Date of the 18 October 2017
transaction
f) Place of the Outside a trading venue
transaction
1) Details of Persons Discharging Managerial
Responsibilities "PDMR" / person closely
associated with them ('PCA')
a) Name Edward Valente
2. Reason for notification
b) Position / PDMR
status
c) Initial notification Initial Notification
/ amendment
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
b) Name Omega Diagnostics Group plc
c) LEI 2138007U9P4BTZTYIR92
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
a) Description Options over ordinary shares
of the financial of 4p each
instrument
Identification GB00B1VCP282
code
b) Nature of Grant of share options under
the transaction the Company's SAYE Scheme
c) Price(s) and Price(s) Volume(s)
volume(s) GBP0.184 78,260
d) Aggregated n/a
information
Aggregated
volume Price
e) Date of the 18 October 2017
transaction
f) Place of the Outside a trading venue
transaction
1) Details of Persons Discharging Managerial
Responsibilities "PDMR" / person closely
associated with them ('PCA')
a) Name Jamie Yexley
2. Reason for notification
b) Position / PDMR
status
c) Initial notification Initial Notification
/ amendment
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
b) Name Omega Diagnostics Group plc
c) LEI 2138007U9P4BTZTYIR92
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
a) Description Options over ordinary shares
of the financial of 4p each
instrument
Identification GB00B1VCP282
code
b) Nature of Grant of share options under
the transaction the Company's SAYE Scheme
c) Price(s) and Price(s) Volume(s)
volume(s) GBP0.184 5,869
d) Aggregated n/a
information
Aggregated
volume Price
e) Date of the 18 October 2017
transaction
f) Place of the Outside a trading venue
transaction
Contacts:
Omega Diagnostics Group Tel: 01259 763 030 PLC Andrew Shepherd, Chief www.omegadiagnostics.com Executive Kieron Harbinson, Group Finance Director Jag Grewal, Group Sales and Marketing Director finnCap Ltd Tel: 020 7220 0500 Geoff Nash/James Thompson (Corporate Finance) Mia Gardner (Corporate Broking) Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com Paul McManus Mob: 07980 541 893 Lianne Cawthorne Mob: 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHFFDSWAFWSEES
(END) Dow Jones Newswires
October 18, 2017 04:00 ET (08:00 GMT)
1 Year Omega Diagnostics Chart |
1 Month Omega Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
